To include your compound in the COVID-19 Resource Center, submit it here.

FDA approves Jazz's Vyxeos for AML

FDA approved Vyxeos (CPX-351) from Jazz Pharmaceuticals plc (NASDAQ:JAZZ) to treat adults with two types of acute myelogenous leukemia --

Read the full 208 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE